Gerardo Guillén
About
In The Last Decade
Gerardo Guillén
149 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 128
- Public Health, Environmental and Occupational Health 1.2k
- Infectious Diseases 1.1k
- Epidemiology 650
- Molecular Biology 509
- Immunology 396
Countries citing papers authored by Gerardo Guillén
This map shows the geographic impact of Gerardo Guillén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo Guillén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo Guillén more than expected).
Fields of papers citing papers by Gerardo Guillén
This network shows the impact of papers produced by Gerardo Guillén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo Guillén. The network helps show where Gerardo Guillén may publish in the future.
Co-authorship network of co-authors of Gerardo Guillén
This figure shows the co-authorship network connecting the top 25 collaborators of Gerardo Guillén. A scholar is included among the top collaborators of Gerardo Guillén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerardo Guillén. Gerardo Guillén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | Comparison between nasopharyngeal swabs and saliva as reliable specimens for the diagnosis of SARS-CoV-2 | 0 |
| 10 | 18 | |
| 11 | 7 | |
| 12 | GHRP-6, a novel candidate for prevention and treatment of fibrotic disorders | 0 |
| 13 | Demostración de la seguridad, inmunogenicidad y evidencias de la eficacia del candidato vacunal HeberNasvac y caracterización de las poblaciones de pacientes con hepatitis B crónica | 1 |
| 14 | Effect of a GnRH vaccine formulation on testosterone concentrations and reproduction in adult male rats | 2 |
| 15 | Effect of human epidermal growth factor on the tumor cell line A431: in vivo analysis of tumor growth inhibition and gene expression | 2 |
| 16 | 20 | |
| 17 | Analysis of the genetic variability and immunological properties of the NlpB antigen, a novel protein identified in Neisseria meningitidis | 0 |
| 18 | Efecto citoprotector cardíaco y extracardíaco del péptido GHRP6 | 3 |
| 19 | Comparison of the immune response induced in mice by five commercial vaccines based on recombinant HBsAg from different sources, implications on their therapeutic use | 1 |
| 20 | Identification of an interleukin-15 antagonist peptide | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.